You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南模生物(688265.SH):2024年度淨利潤約爲656.11萬元,實現扭虧爲盈
格隆匯 02-27 18:44

格隆匯2月27日丨南模生物(688265.SH)公佈2024年度業績快報,報告期內,公司實現營業收入約爲38,193.46萬元,同比增長4.20%;實現歸屬於母公司所有者的淨利潤約爲656.11萬元,實現扭虧爲盈;實現歸屬於母公司所有者的扣除非經常性損益的淨利潤約爲-1,552.07萬元,同比減虧60.72%。

報告期內,公司營業收入有少量增長,一方面,國內科研客戶需求良好,科研端收入穩定增長,但國內生物醫藥行業投融資環境尚未明顯回暖,工業端收入略有下降;另一方面,公司積極開拓海外市場,海外業務收入增速較快。同時公司持續加強生產成本、研發費用和客戶回款的管控,加之理財收益、政府補助等非經常性損益同比有所增加,公司業績實現扭虧爲盈。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account